A Study to Evaluate Single and Multiple Doses of TLC-1180 in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
This phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-ascending doses in healthy subjects.
Epistemonikos ID: c8ab4770318772883d7ac8cc8261b9c2d5b44b86
First added on: Dec 24, 2025